Condition
Regenerative Inflammation
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 3 (1)
P 4 (2)
Trial Status
Completed1
Recruiting1
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07097688Phase 1Active Not RecruitingPrimary
Regenerative Endodontic Treatment Using Sodium Hexametaphosphate (SHMP) For Necrotic Immature Permanent Anterior Teeth
NCT06935747Phase 4Not Yet Recruiting
Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)
NCT06338241Phase 4Recruiting
Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model
NCT03616925Phase 3CompletedPrimary
Evaluation of Platelet Rich Fibrin Matrix as Regenerative Material in Intraosseous Defects
Showing all 4 trials